晚期非小细胞肺癌的治疗:目前的进展和对未来的看法 (综述)
Zeming Wang1, Guoying Cai1, Junquan Zhu1
1Department of Integrative Medicine and Medical Oncology, Shengzhou People's Hospital (Shengzhou Branch of The First Affiliated Hospital of Zhejiang University School of Medicine, Shengzhou Hospital of Shaoxing University), Shengzhou, Zhejiang 312400, P.R. China.
Molecular and clinical oncology
|March 31, 2025
概括
先进的非小细胞肺癌 (NSCLC) 治疗已经超越化疗. 向疗法,免疫疗法和抗体药物合剂提供个性化的选择,改善患者护理和生存结果.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
背景情况:
- 从历史上看,晚期肺癌治疗,主要是化疗,提供了有限的存活率 (<0.5年).
- 最近的医学进步改变了高级非小细胞肺癌 (NSCLC) 的治疗模式.
研究的目的:
- 审查目前NSCLC向疗法,免疫疗法和抗体药物联合体 (ADC) 的突破.
- 探索克服治疗耐药性的挑战,并确定未来的研究方向.
主要方法:
- 对NSCLC的向疗法,免疫疗法和ADC的综合文献综述.
- 分析多式联运组合策略和阻力机制.
- 探索未来的研究途径,包括个性化医疗和多omics生物标志物发现.
主要成果:
- 从传统化疗转向个性化治疗,如向治疗和免疫治疗.
- 新型治疗选择的出现,包括ADC和组合策略.
- 在当前的NSCLC治疗中识别耐药机制和挑战.
结论:
- 未来的NSCLC治疗可能会专注于个性化策略和生物标志物探索,使用多omics数据.
- 持续的研究对于克服耐药性和推进临床决策至关重要.
- 新型疗法为高级NSCLC患者提供了更高的精度和护理.
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...